跳至主要内容
临床试验/NL-OMON35569
NL-OMON35569已完成不适用

Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD. - STONAC

Medisch Spectrum Twente0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • • A clinical diagnosis of stable COPD, as defined by GOLD criteria;• Able to produce sputum;• Age 40 years or over ;• Current or former smoker.

排除标准

  • Exacerbation or use of prednisolone or antibiotics related to an exacerbation 4 weeks prior to enrolment.;• Current pneumonia, defined as an acute respiratory tract illness associated with radiographic shadowing on a chest radiograph which was neither pre-existing nor of any other cause.;• Allergy for penicillin, amoxicillin or clavulanic acid.;• Respiratory insufficiency and hypercapnia measured by arterial blood gas analyses.;• FEV1 postbronchodilator< 1.2 l.

研究者

相似试验